COVID-19 public health emergency ends, but research, lessons go on
Researchers from the University of Michigan School of Public Health discuss the end of the COVID-19 Public Health Emergency.
Infectious Disease
New study details RSV prevalence and outcomes in hospitalized adults
Q&A with Emily Martin
Emily Martin, associate professor of Epidemiology, speaks with editors of the Science Speaks Blog by the Infectious Diseases Society of America to detail a new study about RSV prevalence and outcomes of hospitalized adults.
Examining the association between Malaria and Burkitt lymphoma in sub-Saharan Africa
New research from Kelly Broen
A new study published in Proceedings of the National Academy of Sciences (PNAS) and led by University of Michigan School of Public Health researchers is adding to growing evidence of the association between cumulative malaria infections and endemic Burkitt lymphoma (eBL) in the sub-Saharan African countries of Uganda, Tanzania, and Kenya.
Wastewater dashboard adds monkeypox, flu and more for five southeast Michigan communities
A public dashboard that tracks pathogens detected in wastewater just added monitoring for mpox, influenza-A, norovirus GII and respiratory syncytial virus (RSV). Michigan Public Health researchers Marisa Eisenberg and Betsy Foxman are part of the project.
Looking at 10 years of data, experts recommend improvements to the flu vaccine
Q&A with Arnold Monto
According to a new study published in the journal Clinical Infectious Diseases, while there have been major advances over the last decade in an effort to improve the effectiveness of seasonal influenza vaccine, innovative approaches are needed to significantly improve vaccine effectiveness. Study author Arnold Monto, professor of Epidemiology at the University of Michigan School of Public Health, discusses the findings.
What to know about the new COVID-19 booster shots
Aubree Gordon quoted in the New York Times
A new COVID-19 booster shot for the Omricon variant will be made available. Aubree Gordon, associate professor of Epidemiology at the University of Michigan School of Public Health, describes the number of weeks it takes for anti-bodies from the booster shot to start working.